Analysis of medical malpractice liability disputes related to novel antineoplastic drugs and research on risk prevention and control strategies
Article in PLOS ONE (June 2023)
The most recent citing publications are shown below. View all 61 publications that cite this research output on Dimensions.
Adverse effect of Pneumocystis Jirovecii infection associated with rituximab therapy for autoimmune disease are more frequently reported in older vs. younger patient
Article in Therapie (October 2022)
Off-Label Uses of Rituximab in Dermatology
Article in Current Dermatology Reports (October 2022)